<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0016-3813</journal-id>
<journal-title><![CDATA[Gaceta médica de México]]></journal-title>
<abbrev-journal-title><![CDATA[Gac. Méd. Méx]]></abbrev-journal-title>
<issn>0016-3813</issn>
<publisher>
<publisher-name><![CDATA[Academia Nacional de Medicina de México A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0016-38132026000100017</article-id>
<article-id pub-id-type="doi">10.24875/gmm.25000265</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Salud cardiometabólica de la mujer: diferencias con el hombre]]></article-title>
<article-title xml:lang="en"><![CDATA[Cardiometabolic health in women: differences compared to men]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Basurto]]></surname>
<given-names><![CDATA[Lourdes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Peña-Díaz]]></surname>
<given-names><![CDATA[Aurora De la]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez-Ramos]]></surname>
<given-names><![CDATA[Paola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hiriat-Urdanivia]]></surname>
<given-names><![CDATA[Marcia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Comisión Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad Hospital de la Mujer ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Medicina Departamento de Farmacología]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Nacional de Cardiología Departamento de Biología Molecular ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Comisión Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad Hospital de la Mujer Departamento de Investigación]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto de Fisiología Celular, UNAM Departamento de Neurociencias Cognitivas ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2026</year>
</pub-date>
<volume>162</volume>
<numero>1</numero>
<fpage>17</fpage>
<lpage>22</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0016-38132026000100017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0016-38132026000100017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0016-38132026000100017&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Las enfermedades cardiometabólicas, como la diabetes tipo 2, la hipertensión, las dislipidemias y la enfermedad vascular cerebral, representan las principales causas de mortalidad en América Latina, con un impacto considerable en la población femenina. En México, estas condiciones muestran una prevalencia elevada y creciente, especialmente en mujeres posmenopáusicas, debido a los cambios hormonales que influyen de forma negativa en la función endotelial, el metabolismo lipídico y la resistencia a la insulina. La obesidad abdominal, la prediabetes y la diabetes tipo 2 afectan a una proporción importante de mujeres, y son condiciones que se agravan con la edad. Factores únicos, como la menopausia, el síndrome de ovario poliquístico y los trastornos hipertensivos del embarazo, incrementan más el riesgo cardiovascular. La transición hormonal influye en el perfil lipídico, elevando marcadores como la lipoproteína (a), lo que conlleva un riesgo trombótico. Otras diferencias sexuales en la fisiología cardiovascular, como el tamaño del corazón, la actividad eléctrica y la respuesta vascular, hacen necesario un enfoque de género en la prevención, el diagnóstico y el tratamiento. Se destacan cuatro retos clave: reconocer las diferencias fisiopatológicas, identificar factores de riesgo en la menopausia, detectar y tratar tempranamente prediabetes y dislipidemias, y fortalecer la atención médica primaria con guías específicas para la mujer mexicana.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Cardiometabolic diseases such as type 2 diabetes, hypertension, dyslipidemia, and cerebrovascular disease, are among the leading causes of mortality in Latin America, with a significant impact on the female population. In Mexico, these conditions show a high and increasing prevalence, particularly among postmenopausal women, due to hormonal changes that negatively affect endothelial function, lipid metabolism, and insulin resistance. Abdominal obesity, prediabetes, and type 2 diabetes affect a substantial proportion of women, and tend to worsen with age. Female-specific factors such as menopause, polycystic ovary syndrome, and hypertensive disorders of pregnancy further increase cardiovascular risk. Hormonal transition influences the lipid profile by elevating markers such as lipoprotein (a), thereby increasing thrombotic risk. These sex-based differences in cardiovascular physiology, including heart size, electrical activity, and vascular response, necessitate a tailored approach to prevention, diagnosis, and treatment. Four key challenges are highlighted: recognizing pathophysiological differences, identifying risk factors during menopause, early detection and treatment of prediabetes and dyslipidemia, and strengthening primary healthcare with guidelines specifically designed for Mexican women.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Salud cardiometabólica]]></kwd>
<kwd lng="es"><![CDATA[Posmenopausia]]></kwd>
<kwd lng="es"><![CDATA[Prediabetes]]></kwd>
<kwd lng="es"><![CDATA[Lipoproteína (a)]]></kwd>
<kwd lng="es"><![CDATA[Factores de riesgo cardiovascular]]></kwd>
<kwd lng="en"><![CDATA[Cardiometabolic health]]></kwd>
<kwd lng="en"><![CDATA[Postmenopausal women]]></kwd>
<kwd lng="en"><![CDATA[Prediabetes]]></kwd>
<kwd lng="en"><![CDATA[Lipoprotein (a)]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular risk factors]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsao]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Aday]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Almarzooq]]></surname>
<given-names><![CDATA[ZI]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Beaton]]></surname>
<given-names><![CDATA[AZ]]></given-names>
</name>
<name>
<surname><![CDATA[Bittencourt]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heart disease and stroke statistics - 2022 update:a report from the American Heart Association]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2022</year>
<volume>145</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>153-639</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Instituto Nacional de Estadística y Geografía</collab>
<article-title xml:lang=""><![CDATA[Estadísticas de defunciones registradas, 2023 (preliminar)]]></article-title>
<source><![CDATA[]]></source>
<year>2024</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[INEGI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>Instituto Nacional de Salud Pública</collab>
<article-title xml:lang=""><![CDATA[Encuesta Nacional de Salud y Nutrición ENSANUT Continua 2023]]></article-title>
<source><![CDATA[Cuernavaca]]></source>
<year>2024</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[INSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shamah-Levy]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Vielma-Orozco]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Heredia-Hernández]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Romero-Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mojica-Cuevas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cuevas-Nasu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Encuesta Nacional de Salud y Nutrición 2018-19:Resultados Nacionales]]></article-title>
<source><![CDATA[Cuernavaca, México:Instituto Nacional de Salud Pública]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Brumpton]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Fagerland]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Åsvold]]></surname>
<given-names><![CDATA[BO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex differences in prevalence, treatment, and control of cardiometabolic risk factors:the UK Biobank]]></article-title>
<source><![CDATA[Lancet Healthy Longev]]></source>
<year>2025</year>
<volume>6</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>321-32</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seeland]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Regitz-Zagrosek]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The paradoxical cardiometabolic risk in women:disparities in treatment and outcomes]]></article-title>
<source><![CDATA[Lancet Reg Health Eur.]]></source>
<year>2025</year>
<volume>41</volume>
<page-range>100753</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[DiMaio]]></surname>
<given-names><![CDATA[VJM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Normal organ weights in women:Part I –The heart]]></article-title>
<source><![CDATA[Am J Forensic Med Pathol]]></source>
<year>2015</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>176-81</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Daniels]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex differences in cardiovascular growth during adolescence]]></article-title>
<source><![CDATA[Hypertension]]></source>
<year>1995</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>979-84</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keller]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Howlett]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex differences in the biology and pathology of the aging heart]]></article-title>
<source><![CDATA[Can J Cardiol]]></source>
<year>2016</year>
<volume>32</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1065-73</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maeso]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[De]]></surname>
<given-names><![CDATA[las Heras N]]></given-names>
</name>
<name>
<surname><![CDATA[NavarroCid]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[VázquezPérez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cediel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lahera]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alteraciones endoteliales en el envejecimiento]]></article-title>
<source><![CDATA[Nefrologia]]></source>
<year>1999</year>
<volume>19</volume>
<numero>(Suppl 1)</numero>
<issue>(Suppl 1)</issue>
<page-range>3545</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gorelick]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bhargava]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex differences in the exocrine pancreas and associated diseases]]></article-title>
<source><![CDATA[Cell Mol Gastroenterol Hepatol]]></source>
<year>2021</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>427-41</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orellana-Donoso]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Milos-Brandenberg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Benavente-Urtubia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guerra-Loyola]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bruna-Mejias]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nova-Baeza]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence and clinical implications of anatomical variations in the pancreas and its ductal system:a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Life (Basel)]]></source>
<year>2023</year>
<volume>13</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1710</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saad]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gooren]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Late onset hypogonadism of men is not equivalent to the menopause]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2014</year>
<volume>79</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>389-94</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Putta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yarla]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Lakkappa]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Kamal]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Scotti]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetes mellitus and male aging:pharmacotherapeutics and clinical implications]]></article-title>
<source><![CDATA[Curr Pharm Des]]></source>
<year>2017</year>
<volume>23</volume>
<numero>30</numero>
<issue>30</issue>
<page-range>4471-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benn]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Voss]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Holmegard]]></surname>
<given-names><![CDATA[HN]]></given-names>
</name>
<name>
<surname><![CDATA[Jensen]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
<name>
<surname><![CDATA[Tybjærg-Hansen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nordestgaard]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women]]></article-title>
<source><![CDATA[Arterioscler Thromb Vasc Biol]]></source>
<year>2015</year>
<volume>35</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>471-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[HT]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of estrogen in adipose tissue metabolism:insights into glucose homeostasis regulation]]></article-title>
<source><![CDATA[Endocr J]]></source>
<year>2014</year>
<volume>61</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1055-67</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz-Martínez]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Basurto-Acevedo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Vega-García]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Saucedo-García]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zárate-Treviño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González-Escudero]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación del tejido adiposo visceral y de la concentración de lípidos en mujeres pre y posmenopáusicas]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2016</year>
<volume>84</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>294-300</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Del-Sueldo]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mendonça-Rivera]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Zambrano]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Zilberman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Múnera-Echeverri]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Paniagua]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women]]></article-title>
<source><![CDATA[Arch Cardiol Mex]]></source>
<year>2022</year>
<volume>92</volume>
<numero>(Supl 2)</numero>
<issue>(Supl 2)</issue>
<page-range>1-68</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Córdova-Pérez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Basurto-Acevedo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Degollado-Córdova]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Saucedo-García]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Murillo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zárate-Treviño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Menopausal women have hypofibrinolysis even in subclinical stage of atherosclerosis]]></article-title>
<source><![CDATA[Rev Invest Clin]]></source>
<year>2015</year>
<volume>67</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>122-9</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basurto]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Balcázar-Hernández]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Madrid-Miller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hipertensión y diabetes mellitus en la mujer:una combinación de alto riesgo]]></article-title>
<source><![CDATA[Cardiovasc Metab Sci]]></source>
<year>2024</year>
<volume>35</volume>
<numero>(Suppl 1)</numero>
<issue>(Suppl 1)</issue>
<page-range>11-4</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puente-Barragán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Velázquez-López]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hipertensión a través del ciclo de vida de la mujer:¿quéfactores influyen?]]></article-title>
<source><![CDATA[Cardiovasc Metab Sci]]></source>
<year>2024</year>
<volume>35</volume>
<numero>(Suppl 1)</numero>
<issue>(Suppl 1)</issue>
<page-range>s22-4</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basurto]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Robledo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[García-Vega]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Circulating levels of plasminogen activator inhibitor-1 are associated with metabolic syndrome rather than with menopause]]></article-title>
<source><![CDATA[Gynecol Endocrinol]]></source>
<year>2019</year>
<volume>35</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>909-12</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kronenberg]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipoprotein(a):pathophysiology and clinical relevance]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>2022</year>
<volume>68</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1514-26</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lamon-Fava]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complete and selective estrogenic effects on lipids and cardiovascular disease]]></article-title>
<source><![CDATA[Curr Atheroscler Rep]]></source>
<year>2000</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>72-5</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Peden]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Hopewell]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Kyriakou]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Goel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Heath]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genetic variants associated with Lp(a) lipoprotein level and coronary disease]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2009</year>
<volume>361</volume>
<numero>26</numero>
<issue>26</issue>
<page-range>2518-28</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roeters]]></surname>
<given-names><![CDATA[van Lennep JE]]></given-names>
</name>
<name>
<surname><![CDATA[Tokgözo&#287;lu]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Badimon]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dumanski]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Gulati]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hess]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Women, lipids, and atherosclerotic cardiovascular disease:a call to action from the European Atherosclerosis Society]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2023</year>
<volume>44</volume>
<numero>39</numero>
<issue>39</issue>
<page-range>4157-73</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
